MDL | MFCD00288296 |
---|---|
Molecular Weight | 395.49 |
Molecular Formula | C23H29N3O3 |
SMILES | CCN(CC)CC(N1C2=CC(NC(OCC)=O)=CC=C2CCC3=C1C=CC=C3)=O |
CINPA1 is a potent and specific inhibitor of constitutive androstane receptor (CAR) that does not activate pregnane X receptor (PXR). CINPA1 reduces CAR-mediated transcription with an IC 50 of ~70 nM. CINPA1 can be used as a molecular tool for understanding CAR function [1] .
IC50: ~70 nM (CAR) [1]
CINPA1 (1μM ; 24 hours) inhibits CAR-mediated transactivation without activating PXR in HepG2 cells
[1]
.
CINPA1 is a specific xenobiotic receptor inhibitor and has no cytotoxic effects up to 30 μM
[1]
.
CINPA1 inhibits CAR-mediated gene expression in primary human hepatocytes, where CAR is endogenously expressed
[1]
.
CINPA1 does not alter the protein levels or subcellular localization of CAR
[1]
.
CINPA1 increases corepressor and reduces coactivator interaction with the CAR ligand-binding domain in mammalian two-hybrid assays
[1]
.
CINPA1 disrupts CAR binding to the promoter regions of target genes in chromatin immunoprecipitation assays
[1]
.
CINPA1 efficiently inhibits CAR-LBD interaction with the coactivator peptide that suggesting that CINPA1 is a ligand of CAR
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 250 mg/mL ( 632.13 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.5285 mL | 12.6425 mL | 25.2851 mL |
5 mM | 0.5057 mL | 2.5285 mL | 5.0570 mL |
10 mM | 0.2529 mL | 1.2643 mL | 2.5285 mL |